These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 38329942)

  • 1. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
    Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
    mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
    World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiota-Bile Acid Crosstalk in Diarrhea-Irritable Bowel Syndrome.
    Zhan K; Zheng H; Li J; Wu H; Qin S; Luo L; Huang S
    Biomed Res Int; 2020; 2020():3828249. PubMed ID: 33274207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.
    Dior M; Delagrèverie H; Duboc H; Jouet P; Coffin B; Brot L; Humbert L; Trugnan G; Seksik P; Sokol H; Rainteau D; Sabate JM
    Neurogastroenterol Motil; 2016 Sep; 28(9):1330-40. PubMed ID: 27060367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: A pilot study.
    Wei W; Wang H; Zhang Y; Zhang Y; Niu B; Chen S; Zhang W; Yao S
    Dig Liver Dis; 2021 Sep; 53(9):1120-1127. PubMed ID: 34053874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor/nerve growth factor/transient receptor potential vanilloid 1 axis.
    Li WT; Luo QQ; Wang B; Chen X; Yan XJ; Qiu HY; Chen SL
    FASEB J; 2019 Feb; 33(2):2435-2450. PubMed ID: 30260705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome.
    Zhao L; Yang W; Chen Y; Huang F; Lu L; Lin C; Huang T; Ning Z; Zhai L; Zhong LL; Lam W; Yang Z; Zhang X; Cheng C; Han L; Qiu Q; Shang X; Huang R; Xiao H; Ren Z; Chen D; Sun S; El-Nezami H; Cai Z; Lu A; Fang X; Jia W; Bian Z
    J Clin Invest; 2020 Jan; 130(1):438-450. PubMed ID: 31815740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome.
    Deng X; Xiao L; Luo M; Xie P; Xiong L
    J Gastroenterol Hepatol; 2023 Jul; 38(7):1072-1082. PubMed ID: 36869260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.
    Camilleri M; Carlson P; Acosta A; Busciglio I
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G10-20. PubMed ID: 25930081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review.
    Hou JJ; Wang X; Wang YM; Wang BM
    Crit Rev Microbiol; 2022 Nov; 48(6):696-713. PubMed ID: 34936854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis.
    Wang B; Zhu S; Liu Z; Wei H; Zhang L; He M; Pei F; Zhang J; Sun Q; Duan L
    Genomics Proteomics Bioinformatics; 2020 Dec; 18(6):708-720. PubMed ID: 33607299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine alleviates visceral hypersensitivity in rats by altering gut microbiome and suppressing spinal microglial activation.
    Zhang JD; Liu J; Zhu SW; Fang Y; Wang B; Jia Q; Hao HF; Kao JY; He QH; Song LJ; Liu F; Zhu BL; Owyang C; Duan LP
    Acta Pharmacol Sin; 2021 Nov; 42(11):1821-1833. PubMed ID: 33558654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of five diarrhea-predominant irritable bowel syndrome (IBS-D) rat models in the brain-gut-microbiota axis.
    Wu H; Zhan K; Rao K; Zheng H; Qin S; Tang X; Huang S
    Biomed Pharmacother; 2022 May; 149():112811. PubMed ID: 35303570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid-gut microbiota crosstalk in irritable bowel syndrome.
    Gu Y; Li L; Yang M; Liu T; Song X; Qin X; Xu X; Liu J; Wang B; Cao H
    Crit Rev Microbiol; 2023 May; 49(3):350-369. PubMed ID: 35389754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis.
    Han B; Lv X; Liu G; Li S; Fan J; Chen L; Huang Z; Lin G; Xu X; Huang Z; Zhan L; Lv X
    Gut Microbes; 2023; 15(1):2232143. PubMed ID: 37431863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.